دورية أكاديمية

EE333 Evaluating the Long-Term Clinical, Societal, and Economic Outcomes of Ofatumumab vs Teriflunomide/Interferon Β-1A and the Impact of Early vs Delayed Ofatumumab Initiation in Relapsing Multiple Sclerosis Patients in Greece

التفاصيل البيبلوغرافية
العنوان: EE333 Evaluating the Long-Term Clinical, Societal, and Economic Outcomes of Ofatumumab vs Teriflunomide/Interferon Β-1A and the Impact of Early vs Delayed Ofatumumab Initiation in Relapsing Multiple Sclerosis Patients in Greece
المؤلفون: Petropoulos, A, Vudumula, U, Patidar, M, Tiwari, S, Brennan, R, Kapsogeorgiou, K, Cheilas, G, Banhazi, J
المصدر: In Value in Health December 2022 25(12) Supplement:S119-S120
قاعدة البيانات: ScienceDirect
الوصف
تدمد:10983015
DOI:10.1016/j.jval.2022.09.579